GNOM

Global X Genomics & Biotechnology ETF [GNOM] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

GNOM Stock Summary

Top 10 Correlated ETFs

GNOM


Top 10 Correlated Stocks

GNOM


In the News

03:49 28 Mar 2024 GNOM

GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment

GNMO invests across companies benefiting from advancements in the field of genomics within biotechnology. The fund's historical performance has been poor amid volatile stock prices for underlying holdings. Genomics may be the future, but still missing a blockbuster application to drive a wave of bullish momentum into the segment.

04:19 28 Mar 2024 GNOM

3 Stocks That Could Be the Next Big Thing in Gene Editing

Gene editing could revolutionize how millions of patients are treated all over the world. That could create big opportunities for some of the most exciting gene-editing stocks.

06:05 28 Mar 2024 GNOM

3 Gene Editing Stocks With Unprecedented Surge Potential

Gene editing is revolutionizing medicine. For example, just weeks ago, the U.S. Federal Drug Administration approved a new gene-editing treatment for sickle cell disease and transfusion-dependent beta-thalassemia, a genetic disorder that prevents the production of hemoglobin in the blood and requires regular blood transfusions.

12:28 28 Mar 2024 GNOM

3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential

Some of the top gene-editing stocks have had immense surge potential. Look at CRISPR Therapeutics (NASDAQ: CRSP ), for example.

11:05 28 Mar 2024 GNOM

3 Gene Editing Stocks to Generate Super-Charged Gains

Gene editing is revolutionizing how the world approaches medicine. In fact, by “simply” removing cells from the body, editing them, and reintroducing them, we could help treat sickle-cell anemia, cancers, blood disorders, blindness, cystic fibrosis, and even muscular dystrophy if all goes according to plan.

08:15 28 Mar 2024 GNOM

Healthcare Dashboard For August And Focus On GNOM

This article provides a dashboard with industry metrics in healthcare, then focus on the Global X Genomics & Biotechnology ETF. Pharmaceuticals/biotechnology and healthcare providers have fair value and quality scores. Healthcare equipment is the most overvalued subsector.

04:02 28 Mar 2024 GNOM

GNOM: A Genomics ETF That Will Have Its Day, Even If Not Right Now

GNOM is a $200 million ETF that invests in a forward-looking set of innovative businesses focused on the genomics industry. This is a long-term growth area, but it will need to get more profitable to get more popular. That could take a little while.

09:17 28 Mar 2024 GNOM

The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket

CRISPR could revolutionize the way we treat thousands of diseases. Currently, there are about 7,000 caused by genetic disorders, which occur when a mutation affects your genes, or when you have the wrong amount of genetic material, as noted by the Cleveland Clinic.

11:31 28 Mar 2024 GNOM

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector

Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.

09:02 28 Mar 2024 GNOM

Will 2023 be the Year of Cathie Wood ETFs?

Cathie Wood, famous for the success of Ark Investment???s winning products, had faced a miserable fate in 2022.

GNOM Financial details

Company Rating
Neutral
Market Cap
97.68M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-8.33%
SMA50
-
SMA100
22.22%
Inst Own
0%
Inst Trans
0%
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
8.82M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
8.63-13.33
52W High
-12.35%
52W Low
+42.44%
RSI
49
Rel Volume
0.49
Avg Volume
70.87K
Volume
34.63K
Perf Week
-0.48%
Perf Month
-0.39%
Perf Quarter
14.75%
Perf Half Y
13.16%
-
-
-
-
Beta
1.19
-
-
Volatility
0.09%, 0.32%
Prev Close
-0.31%
Price
11.395
Change
0.49%

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap